iS CLINICAL – Retinol + Emulsion 0.3
R2572,00
Size: 30g
iS Clinical Retinol+ Emulsion 0.3 being a resurfacing formula that helps reduce the appearance of fine lines, and helps even skin tone while smoothing skin texture for a radiant complexion. Suitable for early and mature ageing concerns.
Best for: Retinol booster serum for early & mature ageing skin
How to use:
- Nighttime use only.
- Apply 2-3 pumps to clean skin, smoothing evenly over face and neck.
- Introduce slowly, starting 2 x a week for 2 weeks and then increase to 3 x a week.
- Reduce frequency if skin shows signs of sensitivity.
- Always use a broad spectrum, high factor sunscreen daily.
Key Ingredients:
- 3% Retinol (Vitamin A)
- 1% Bakuchiol
- Copper Tripeptides
- Ectoin
- Botanical Extracts
Benefits:
- Promotes the synthesis of collagen while increasing cellular turnover.
- Soothes and restores the skin barrier.
- Helps to prevent fine lines and wrinkles.
- Provides superior oxidative protection.
- Boosts antioxidant activity against environmental stresses while brightening.
- Shealds DNA from environmental stresses.
- Supports healing and regeneration.
- Reduces the appearance of ageing skin and boosts collagen synthesis.
Frequently purchased with:
- iS Clinical Youth Intensive Crème
- iS Clinical Super Serum Advance +
- iS Clinical GeneXC Serum
Pay over 3 EQUAL zero-interest instalments of R857,34 with PayJustNow.
Find out how...
HOW IT WORKS
PayJustNow allows you to pay for your purchase over 3 payments with 0% interest and no fees. Pay a third at checkout and receive your goods immediately. The remaining two instalments are debited on your selected instalment dates.
Browse online or in-store and proceed to checkout
Choose PayJustNow as your payment method
Create your account and receive an instant approval decision
Complete your transaction
WHAT YOU WILL NEED
Be over 18 years old
Be a South African resident
Have a debit or credit card
Have a valid email address
0% INTEREST. 3 PAYMENTS. NO STRESS.
WHY PAY ANY OTHER WAY?


There are no reviews yet.